First published 9/30/2026, 8:02:15 AM · Last updated 9/30/2026, 8:02:15 AM

Schwellenabhängiges Risiko für multiresistente Erreger unter Antibiotikatherapie bei Leberzirrhose: Ergebnisse einer prospektiven Kohortenstudie

This journal article reports results of a prospective cohort study on threshold-dependent risk for multidrug-resistant pathogens during antibiotic therapy in patients with liver cirrhosis. The supplied source data include only the title, publisher, DOI, and publication date and provide no study details or outcomes.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 3/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study topic is relevant to clinical management of antibiotic use and surveillance of antimicrobial resistance in patients with liver cirrhosis.

Sources

Schwellenabhängiges Risiko für multiresistente Erreger unter Antibiotikatherapie bei Leberzirrhose: Ergebnisse einer prospektiven Kohortenstudie

Report an issue